Other OTC - Delayed Quote USD

Guided Therapeutics, Inc. (GTHP)

0.1080 +0.0170 (+18.68%)
At close: April 23 at 10:27 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
98.0000
98.0000
13.0000
81.0000
102.0000
Cost of Revenue
62.0000
62.0000
81.0000
61.0000
-41.0000
Gross Profit
36.0000
36.0000
-68.0000
20.0000
143.0000
Operating Expense
3,493.0000
3,493.0000
3,265.0000
2,382.0000
1,195.0000
Operating Income
-3,457.0000
-3,457.0000
-3,333.0000
-2,362.0000
-1,052.0000
Net Non Operating Interest Income Expense
-272.0000
-272.0000
-582.0000
-1,150.0000
-1,056.0000
Other Income Expense
240.0000
240.0000
-426.0000
1,442.0000
1,829.0000
Pretax Income
-3,489.0000
-3,489.0000
-4,341.0000
-2,070.0000
-279.0000
Net Income Common Stockholders
-3,759.0000
-3,759.0000
-4,972.0000
-2,431.0000
-401.0000
Diluted NI Available to Com Stockholders
-3,759.0000
-3,759.0000
-4,972.0000
-2,431.0000
-401.0000
Basic EPS
-0.07
--
-0.15
-0.18
-0.04
Diluted EPS
-0.07
--
-0.15
-0.18
-0.04
Basic Average Shares
51,131.0000
--
32,505.0000
13,377.0000
10,767.0000
Diluted Average Shares
51,131.0000
--
32,505.0000
13,377.0000
10,767.0000
Total Operating Income as Reported
-3,457.0000
-3,457.0000
-3,333.0000
-2,362.0000
-1,052.0000
Total Expenses
3,555.0000
3,555.0000
3,346.0000
2,443.0000
1,154.0000
Net Income from Continuing & Discontinued Operation
-3,489.0000
-3,489.0000
-4,341.0000
-2,070.0000
-279.0000
Normalized Income
-3,690.0000
-3,690.0000
-3,899.0000
-3,005.0000
-1,837.0000
Interest Income
6.0000
6.0000
--
--
--
Interest Expense
278.0000
278.0000
582.0000
1,150.0000
1,056.0000
Net Interest Income
-272.0000
-272.0000
-582.0000
-1,150.0000
-1,056.0000
EBIT
-3,211.0000
-3,211.0000
-3,759.0000
-920.0000
777.0000
EBITDA
-3,126.0000
-3,126.0000
-3,687.0000
-837.0000
777.0000
Reconciled Cost of Revenue
62.0000
62.0000
81.0000
61.0000
-41.0000
Reconciled Depreciation
85.0000
85.0000
72.0000
83.0000
--
Net Income from Continuing Operation Net Minority Interest
-3,489.0000
-3,489.0000
-4,341.0000
-2,070.0000
-279.0000
Total Unusual Items Excluding Goodwill
201.0000
201.0000
-442.0000
935.0000
1,558.0000
Total Unusual Items
201.0000
201.0000
-442.0000
935.0000
1,558.0000
Normalized EBITDA
-3,327.0000
-3,327.0000
-3,245.0000
-1,772.0000
-781.0000
12/31/2020 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QTRX Quanterix Corporation
16.10
-1.23%
 
LFWD ReWalk Robotics Ltd.
4.8900
0.00%
 
CATX Perspective Therapeutics, Inc.
1.7000
+11.11%
 
IART Integra LifeSciences Holdings Corporation
29.38
+1.38%
 
BTCY Biotricity, Inc.
1.4500
-2.03%
 
ASXC Asensus Surgical, Inc.
0.2490
-0.40%
 
CUTR Cutera, Inc.
2.1500
+10.82%
 
SINT Sintx Technologies, Inc.
0.0358
-5.79%